NIH #U01CA260731
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor
Active
- Amount
- $900K–$1000K
- Period
- 2022-09-01 → 2027-08-31
- PIs
- 3
Awarded at UNIVERSITY OF VIRGINIA
Qianqian Zhu
Full Professor(heuristic)
Genetic Associations and Epidemiology · Genetics
Compare more Genetics professors.
h-index40
i10-index122
Publications294
Citations5,479
Grants
3 total · 1 active
NIH #R01CA262899
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation
- Amount
- $900K–$1000K
- Period
- 2021-08-01 → 2026-07-31
- PIs
- 3
Awarded at ROSWELL PARK CANCER INSTITUTE CORP
NIH #R03CA223730
Genetic underpinnings of ethnic disparities in bone toxicities between Hispanic and non-Hispanic children treated for acute lymphoblastic leukemia
- Amount
- <$100K
- Period
- 2017-12-05 → 2019-11-30
- PIs
- 3
Awarded at ROSWELL PARK CANCER INSTITUTE CORP
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New preprint: A Circulating Proteomic Signature of Allostatic Load Predicts Multisystem Disease and Mortality2026-04-16
- New paper: Ginsenoside Rh2 as a novel PIN1 inhibitor disrupting the cancer stem cell-like phenotype in non-small cell lung cancer (Journal of Translational Medicine)2025-11-10
- New NIH award: Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor2022-09-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-26
Data may not be current
Find elsewhere
ORCID: 0000-0003-2516-6675